Loading...
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
Trabectedin is the first marine-derived anti-neoplastic drug approved for the treatment of advanced soft tissue sarcoma and, in combination with pegylated liposomal doxorubicin, for the treatment of patients with relapsed platinum-sensitive ovarian cancer. From the beginning of its development, trab...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4134488/ https://ncbi.nlm.nih.gov/pubmed/24755886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.149 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|